Avinger, Inc. (NASDAQ:AVGR – Get Free Report) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.41 and traded as high as $3.80. Avinger shares last traded at $3.69, with a volume of 3,255 shares trading hands.
Analyst Upgrades and Downgrades
Several research firms have issued reports on AVGR. HC Wainwright restated a “buy” rating and set a $5.00 price objective on shares of Avinger in a report on Thursday, March 21st. StockNews.com initiated coverage on shares of Avinger in a research report on Wednesday. They set a “hold” rating for the company.
View Our Latest Stock Report on AVGR
Avinger Stock Performance
Avinger (NASDAQ:AVGR – Get Free Report) last announced its quarterly earnings data on Wednesday, March 20th. The medical device company reported ($3.93) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by ($4.57). The business had revenue of $1.91 million during the quarter, compared to analysts’ expectations of $2.52 million. On average, analysts forecast that Avinger, Inc. will post -2.08 earnings per share for the current fiscal year.
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Recommended Stories
- Five stocks we like better than Avinger
- 3 Warren Buffett Stocks to Buy Now
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is an Earnings Surprise?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- 3 Fintech Stocks With Good 2021 Prospects
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.